Disc Medicine IRON Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -35.8%0.0pp | -35.9%-1.1pp | -34.8%-8.4pp | -26.4%-3.0pp | -23.3%+4.4pp | |
| Return on invested capital | -44.3%+4.8pp | -49.1%+5.8pp | -55%-8.6pp | -46.4%— | —— | |
| Liquidity | ||||||
| Current ratio | 24×+2.1× | 21.9×-1.5× | 23.5×-8.7× | 32.1×-5.5× | 37.7×+16.5× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $17.89-14.7% | $20.96+28.6% | $16.30-7.0% | $17.54-11.5% | $19.82+23.3% | |
| Valuation | ||||||
| Market capitalization | $2.44B-18.6% | $3B+30.5% | $2.3B+20.6% | $1.9B+11.0% | $1.72B-9.0% | |
| Price / book | 3.5×-0.5× | 4.1×0.0× | 4×+0.9× | 3.1×+0.5× | 2.6×-1.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Disc Medicine's ratios come from?
- Every ratio is computed from Disc Medicine's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.